DK1899343T3 - Halogenerede pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelser som GABA-A-receptorligand, sammensætninger og mellemprodukter - Google Patents

Halogenerede pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelser som GABA-A-receptorligand, sammensætninger og mellemprodukter

Info

Publication number: DK1899343T3
Authority: DK; Denmark
Prior art keywords: gaba; pyrimidines; intermediates; compositions; methods
Prior art date: 2005-06-21

Application number

DK06763737.1T

Other languages

English (en)

Inventor

Luis Anglada

Albert Palomer

Antonio Guglietta

Original Assignee

Ferrer Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-21

Filing date

2006-06-15

Publication date

2010-09-06

2006-06-15 Application filed by Ferrer Int filed Critical Ferrer Int

2010-09-06 Application granted granted Critical

2010-09-06 Publication of DK1899343T3 publication Critical patent/DK1899343T3/da

Links

102000004300 GABA-A Receptors Human genes 0.000 title 1
108090000839 GABA-A Receptors Proteins 0.000 title 1
239000000543 intermediate Substances 0.000 title 1
239000003446 ligand Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1
LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical class N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK06763737.1T 2005-06-21 2006-06-15 Halogenerede pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelser som GABA-A-receptorligand, sammensætninger og mellemprodukter DK1899343T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US69286605P	2005-06-21	2005-06-21
EP05105478A EP1736475A1 (en)	2005-06-21	2005-06-21	Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
PCT/EP2006/063243 WO2006136530A1 (en)	2005-06-21	2006-06-15	Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates

Publications (1)

Publication Number	Publication Date
DK1899343T3 true DK1899343T3 (da)	2010-09-06

Family

ID=35311853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06763737.1T DK1899343T3 (da)	2005-06-21	2006-06-15	Halogenerede pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelser som GABA-A-receptorligand, sammensætninger og mellemprodukter

Country Status (24)

Country	Link
US (3)	US8530482B2 (da)
EP (2)	EP1736475A1 (da)
JP (1)	JP5010591B2 (da)
KR (1)	KR101465802B1 (da)
CN (1)	CN101243089B (da)
AR (1)	AR054785A1 (da)
AT (1)	ATE467635T1 (da)
AU (1)	AU2006261025B2 (da)
BR (1)	BRPI0612075A2 (da)
CA (1)	CA2612726C (da)
CY (1)	CY1111452T1 (da)
DE (1)	DE602006014272D1 (da)
DK (1)	DK1899343T3 (da)
ES (1)	ES2345999T3 (da)
MX (1)	MX2007016340A (da)
NO (1)	NO339973B1 (da)
PE (1)	PE20070071A1 (da)
PL (1)	PL1899343T3 (da)
PT (1)	PT1899343E (da)
RU (1)	RU2478101C2 (da)
SI (1)	SI1899343T1 (da)
TW (1)	TWI382985B (da)
UY (1)	UY29618A1 (da)
WO (1)	WO2006136530A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1736475A1 (en)	2005-06-21	2006-12-27	Ferrer Internacional, S.A.	Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
US20070219186A1 (en) *	2006-03-17	2007-09-20	Wyeth	Pyrazolo[1,5-A]pyrimidine derivatives and methods of use thereof
EP1884516A1 (en)	2006-08-04	2008-02-06	Ferrer Internacional, S.A.	Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
EP1918290A1 (en) *	2006-10-11	2008-05-07	Ferrer Internacional, S.A.	Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP1956021A1 (en)	2006-10-11	2008-08-13	Ferrer Internacional, S.A.	Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
EP1921079A1 (en) *	2006-11-08	2008-05-14	Ferrer Internacional, S.A.	Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
PT2387557E (pt)	2009-01-13	2013-09-11	Interquim Sa	Processo para a preparação de n-[5-(3-dimetilaminoacriloil)- 2-fluorofenil]-n-metil-acetamida
US9624184B2 (en)	2013-04-04	2017-04-18	Takeda Pharmaceutical Company Limited	Heterocyclic compound
JP2018199623A (ja) *	2015-10-22	2018-12-20	大正製薬株式会社	含窒素縮合複素環化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4521422A (en) *	1983-06-23	1985-06-04	American Cyanamid Company	Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US6399621B1 (en) *	1999-08-10	2002-06-04	American Cyanamid Company	N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
PT1368355E (pt) *	2001-03-14	2006-09-29	Gruenenthal Gmbh	Pirazolopirimidinas e tiazolopirimidinas substituidas, como analgesicos
DE60206072T2 (de) *	2001-12-21	2006-07-13	Bayer Healthcare Ag	Aroylpyridinone
ES2222813B1 (es) *	2003-07-24	2005-12-16	Ferrer Internacional, S.A.	N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
WO2006033795A2 (en) *	2004-09-17	2006-03-30	Wyeth	Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
WO2006033796A1 (en) *	2004-09-17	2006-03-30	Wyeth	SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME
CN100528875C (zh)	2005-02-18	2009-08-19	美德（江西）生物科技有限公司	无结晶型态的印地普隆及其制备方法
EP1736475A1 (en) *	2005-06-21	2006-12-27	Ferrer Internacional, S.A.	Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

2005
- 2005-06-21 EP EP05105478A patent/EP1736475A1/en not_active Withdrawn
2006
- 2006-06-15 MX MX2007016340A patent/MX2007016340A/es active IP Right Grant
- 2006-06-15 ES ES06763737T patent/ES2345999T3/es not_active Expired - Lifetime
- 2006-06-15 SI SI200630735T patent/SI1899343T1/sl unknown
- 2006-06-15 WO PCT/EP2006/063243 patent/WO2006136530A1/en not_active Ceased
- 2006-06-15 BR BRPI0612075-0A patent/BRPI0612075A2/pt not_active Application Discontinuation
- 2006-06-15 JP JP2008517470A patent/JP5010591B2/ja not_active Expired - Fee Related
- 2006-06-15 DK DK06763737.1T patent/DK1899343T3/da active
- 2006-06-15 PT PT06763737T patent/PT1899343E/pt unknown
- 2006-06-15 EP EP06763737A patent/EP1899343B1/en not_active Expired - Lifetime
- 2006-06-15 CA CA2612726A patent/CA2612726C/en not_active Expired - Fee Related
- 2006-06-15 KR KR1020087001565A patent/KR101465802B1/ko not_active Expired - Fee Related
- 2006-06-15 US US11/922,602 patent/US8530482B2/en not_active Expired - Fee Related
- 2006-06-15 RU RU2008101371/04A patent/RU2478101C2/ru not_active IP Right Cessation
- 2006-06-15 AU AU2006261025A patent/AU2006261025B2/en not_active Ceased
- 2006-06-15 PL PL06763737T patent/PL1899343T3/pl unknown
- 2006-06-15 AT AT06763737T patent/ATE467635T1/de active
- 2006-06-15 CN CN2006800303968A patent/CN101243089B/zh not_active Expired - Fee Related
- 2006-06-15 DE DE602006014272T patent/DE602006014272D1/de not_active Expired - Lifetime
- 2006-06-19 TW TW095121824A patent/TWI382985B/zh not_active IP Right Cessation
- 2006-06-19 PE PE2006000684A patent/PE20070071A1/es active IP Right Grant
- 2006-06-20 AR ARP060102604A patent/AR054785A1/es active IP Right Grant
- 2006-06-21 UY UY29618A patent/UY29618A1/es active IP Right Grant
2008
- 2008-01-21 NO NO20080393A patent/NO339973B1/no not_active IP Right Cessation
2010
- 2010-08-11 CY CY20101100750T patent/CY1111452T1/el unknown
2013
- 2013-08-13 US US13/965,516 patent/US10072000B2/en not_active Expired - Fee Related
- 2013-08-13 US US13/965,383 patent/US20130331610A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CY1111452T1 (el)	2015-08-05
CN101243089B (zh)	2011-07-06
KR101465802B1 (ko)	2014-11-27
CA2612726A1 (en)	2006-12-28
KR20080032104A (ko)	2008-04-14
EP1899343A1 (en)	2008-03-19
AU2006261025B2 (en)	2011-09-08
US20160368912A9 (en)	2016-12-22
US20130331610A1 (en)	2013-12-12
CA2612726C (en)	2013-10-01
ES2345999T3 (es)	2010-10-07
RU2008101371A (ru)	2009-07-27
PL1899343T3 (pl)	2010-10-29
NO339973B1 (no)	2017-02-27
TW200726769A (en)	2007-07-16
CN101243089A (zh)	2008-08-13
EP1736475A1 (en)	2006-12-27
UY29618A1 (es)	2006-10-31
TWI382985B (zh)	2013-01-21
PT1899343E (pt)	2010-08-17
WO2006136530A1 (en)	2006-12-28
US8530482B2 (en)	2013-09-10
US20130331401A1 (en)	2013-12-12
AR054785A1 (es)	2007-07-18
BRPI0612075A2 (pt)	2010-10-19
DE602006014272D1 (de)	2010-06-24
NO20080393L (no)	2008-03-10
SI1899343T1 (sl)	2010-09-30
HK1116184A1 (en)	2008-12-19
US10072000B2 (en)	2018-09-11
RU2478101C2 (ru)	2013-03-27
US20090111848A1 (en)	2009-04-30
JP2008543913A (ja)	2008-12-04
AU2006261025A1 (en)	2006-12-28
PE20070071A1 (es)	2007-02-01
EP1899343B1 (en)	2010-05-12
MX2007016340A (es)	2008-03-10
JP5010591B2 (ja)	2012-08-29
ATE467635T1 (de)	2010-05-15

Publication	Publication Date	Title
IL177259A0 (en)	2006-12-10	Heteroaryl -fused pyrazolo derivatives
ZA200802497B (en)	2009-03-25	Imidazo [1,2-A] pyridine having anti-cell-proliferation actvity
NO20053955D0 (no)	2005-08-25	Pyrazolo [1,5-A] pyrimidinderivater
DK1966202T3 (da)	2012-01-16	Heteroarylsubstituerede pyrrolo[2,3-b]pyridiner og pyrrolo[2,3-d]pyrimidiner som Januskinaseinhibitorer
DE122012000043I1 (de)	2012-09-13	Pyrrolo[2,3-B]pyridinderivate als proteinkinaseinhibitoren.
ZA200708187B (en)	2008-11-26	Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-D]pyrimidine derivatives
IL182963A0 (en)	2007-08-19	Imidazo[1,2-a] pyridine compounds, compositions, uses and methods related thereto
DK1888580T3 (da)	2010-06-14	Pyrido[2,3-D]pyrimidiner, der er egnede som HCV-hæmmere, og fremgangsmåde til fremstillingen af disse
IL194010A (en)	2015-10-29	Pyrzolido [4,3– d] derivatives, pyrimidine containing preparations and their use
PL2217578T3 (pl)	2014-05-30	Związki [1,2,4]triazolo[1,5-a]pirydyny i [1,2,4]triazolo[1,5-c]pirymidyny i ich zastosowanie
EP1734820A4 (en)	2008-01-23	Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
IL206466A0 (en)	2010-12-30	PYRAZOLO [1,5-a]PYRIMIDINES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
NO20054330D0 (no)	2005-09-20	8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
NO20054331D0 (no)	2005-09-20	Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
BRPI0822239A2 (pt)	2015-06-30	Composto de pirazolo[1,5-a] pirimidina
ZA200804335B (en)	2010-05-26	Substituted bicyclic pyrimidone derivatives
ZA200803173B (en)	2009-01-28	Pyrazolo [4,3-d] Pyrimidin-5-yl) Derivative used as PDE5 Inhibitors
ZA200801893B (en)	2009-08-26	Amorphous solid dispersions of 7-chloro-N,N, 5-Trimethyl-4-Oxo-3-phenyl-3, 5,-dihydro-4H-pyridazino [4,5-B] indole-1-acetamide
PL1899343T3 (pl)	2010-10-29	Fluorowcowane pirazolo[1,5-a]pirymidyny, sposób ich wytwarzania, ich zastosowanie jako ligandów receptorów GABA-A, kompozycje je zawierające i związki pośrednie
ZA200705035B (en)	2009-06-24	Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity
DK2059521T3 (da)	2010-09-27	Pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelse og sammensætninger
DK1902054T3 (da)	2009-06-15	Pyrido[2,3-d]pyrimidinderivater, fremstilling og terapeutisk anvendelse heraf
GB2433993B (en)	2010-04-28	Single molecule TR-FRET probe
GB0423007D0 (en)	2004-11-17	Foldable chair for bathroom
HK1112231A (en)	2008-08-29	Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors